Patents
Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
08/2004
08/11/2004EP1444248A2 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
08/10/2004CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes
08/04/2004EP1443051A2 Sugar modified oligonucleotides that detect and modulate gene expression
07/2004
07/29/2004WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/28/2004EP1441224A2 Enzyme inhibition immunoassay
07/27/2004US6767904 Steroid derived antibiotics
07/22/2004US20040142899 Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals
07/21/2004EP1438299A1 Bifunctional chelating agent for actinium
07/21/2004CN1158299C Substituted 4-benzylaminoquinoline, method for producing the same, medicaments containing these compounds and their use
07/15/2004WO2004045536A3 Method and compositions for temporarily incapaciting subjets
07/15/2004US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto
07/14/2004EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression
07/08/2004US20040131666 Liposome encapsulating active materials
07/01/2004WO2004000802A3 Scaffolded maleimide clusters for multivalent peptide assembly
06/2004
06/29/2004US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/24/2004US20040120997 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system
06/23/2004EP1429779A2 Androstanes as androgen receptor modulators
06/22/2004US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents
06/22/2004US6753423 For preferentially modulated gene expression in liver and associated tissues
06/16/2004EP1218401B1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
06/16/2004EP1058552B1 Steroid derived antibiotics
06/15/2004US6750238 Aralkyl ester soft drugs
06/10/2004WO2004037843A3 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
06/08/2004US6747018 Treatment of estrogen-dependent disorders; preferred compounds have 1,3,5-estratriene nucleus, and are substituted at c-17 or c-11 with molecular moiety which renders compounds effective to block binding of estrogen to its receptor
06/03/2004WO2004045536A2 Method and compositions for temporarily incapaciting subjets
06/03/2004WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/03/2004US20040106154 In vivo screen using chemical inducers of dimerization
06/03/2004CA2503316A1 Method and compositions for temporarily incapacitating subjects
06/03/2004CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
05/2004
05/27/2004WO2004043986A1 Processes for preparing c-7 substituted 5-androstenes
05/27/2004CA2500580A1 Processes for preparing c-7 substituted 5-androstenes
05/26/2004EP0740650B1 Codrugs as a method of controlled drug delivery
05/26/2004CN1151161C Medicine nitrate salts
05/25/2004US6740645 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
05/20/2004US20040097475 Reacting steroid intermediate with nucleophilic reagent in presence of Lewis acid catalyst to produce 7-substituted steroid compound
05/12/2004EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression
05/06/2004WO2004037843A2 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
05/06/2004EP0775155B1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them
04/2004
04/28/2004CN1492876A Amphoteric sterols and the use thereof
04/22/2004WO2004005310A3 New compounds, compositions and methods for treatment of inflammatory diseases and conditions
04/22/2004US20040077612 Acting as prodrugs; higher concentration delivery of active material to target cell in hybrid form; decreasing side effects
04/21/2004EP1408981A1 Methods for preventing antipsychotic-induced weight gain
04/21/2004CN1491230A Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
04/07/2004EP1404717A1 Kinetic assay
04/01/2004WO2003089449A3 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
03/2004
03/31/2004EP1401856A2 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
03/17/2004EP0731807B1 N-2 substituted purines
03/11/2004US20040048826 Oligonucleotides containing 2'-0-modified purines
03/10/2004EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives
03/03/2004EP1392714A1 Steroids as agonists for fxr
02/2004
02/26/2004WO2003064443A3 New corticosteroids
02/26/2004WO2003026568A3 Androstanes as androgen receptor modulators
02/19/2004US20040034216 A gonane ring or with the nitrogen forming a heterocyclic structure; antiinflammation agents, antitumor agents; treating asthma, allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, AIDS, arrhythmias
02/19/2004US20040034002 3Alpha-hydroxy-3beta-methoxymethyl-substituted steroids and the use thereof
02/17/2004US6693090 19-norsteroids substituted in position 11β, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them
02/12/2004US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
02/05/2004US20040024231 Such as 17-beta-hydroxy-17-alpha-trifluoromethyl-7-alpha-methyl-androst-4-en-3-one; for hormone replacement therapy
02/05/2004US20040023936 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
01/2004
01/22/2004US20040014685 Compounds, compositions and methods for treatment of inflammatory diseases and conditions
01/21/2004EP1382340A1 Therapeutic uses of dehydroepiandrosterone for treating diminished libido and osteoporosis
01/20/2004US6680310 Methods for preventing antipsychotic-induced weight gain
01/15/2004WO2004005313A2 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
01/15/2004WO2004005310A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions
01/15/2004CA2489402A1 New compounds, compositions and methods for treatment of inflammatory diseases and conditions
01/14/2004CN1468253A 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
01/14/2004CN1468252A 6.alpha., 9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
01/08/2004US20040006051 Estrogen-linked platinum (II) complexes as anticancer agents
01/07/2004CN1466592A 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds
12/2003
12/31/2003WO2004000802A2 Scaffolded maleimide clusters for multivalent peptide assembly
12/31/2003CA2490124A1 Scaffolded maleimide clusters for multivalent peptide assembly
12/30/2003US6670393 Carbamate-based cationic lipids
12/30/2003US6670348 Antitumor geldanamycins
12/18/2003US20030232791 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
12/17/2003CN1131237C Usage of steroi saponin for preventing and curing senile dementia and new steroi saponin
12/17/2003CN1131235C 11'beta-halogen-7alpha-substd estratrienes, Preparation of Pharmaceutical preparation containing 11'beta'-halogen-7alpha-substd estratrienes
12/10/2003EP1077992B1 Use of meiosis regulating compounds
12/09/2003CA2094457C Monoquaternary 2,16-bispiperidinylandrostane derivatives
12/04/2003WO2003070194A3 Amino acid and peptide-modified forms of glucocorticoids
12/02/2003CA2118565C Process for the preparation of 3.beta.-aminocholanic acid derivatives
11/2003
11/27/2003US20030220313 Comprises estrogen/antiestrogen-porphyrin conjugate
11/26/2003EP1363933A2 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
11/26/2003EP1363932A2 Amphoteric sterols and the use thereof
11/20/2003US20030216362 Estra-1,3,5 (10)-triene derivatives
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/06/2003US20030207431 Properties of mycophenolic acid inhibition of IMPDH (inosine-5'-monophosphate dehydrogenase) that allow the development of the immunoassay; drug conjugates with an uncompetitive inhibitor of IMPDH, mycophenolic acid
10/2003
10/30/2003WO2003089449A2 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/30/2003US20030203871 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/23/2003US20030199485 Novel anti-inflammatory androstane derivative
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003CA2130926C Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
10/16/2003WO2002079220A3 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
10/15/2003EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
10/09/2003US20030191102 Contraception method using competitive progesterone antagonists and novel compounds useful therein
10/09/2003US20030191099 Antiestrogen compound
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/02/2003US20030187240 Nuclease resistant
09/2003
09/30/2003CA2114630C Steroid sulphatase inhibitors
09/23/2003US6624156 Methods of making and method of using hybrid cholinergic agents and compositions
09/23/2003US6624155 Hybrid cholinergic agents and compositions
09/23/2003CA2082936C Fluorescent porphyrin, and fluorescent phthalocyanine-polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 26